Q2 2014 13F Holders as of 6/30/2014
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41M
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
1.43M
-
Shares change
-
+114K
-
Total reported value, excl. options
-
$13.7M
-
Value change
-
+$928K
-
Put/Call ratio
-
3.98
-
Number of buys
-
9
-
Number of sells
-
-9
-
Price
-
$9.62
Significant Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q2 2014
29 filings reported holding ORMP - ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share as of Q2 2014.
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.43M shares
of 41M outstanding shares and own 3.48% of the company stock.
Largest 10 shareholders include MARXE AUSTIN W & GREENHOUSE DAVID M (790K shares), STIFEL FINANCIAL CORP (414K shares), GREYLIN INVESTMENT MANGEMENT INC (91.2K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (28.6K shares), D. E. Shaw & Co., Inc. (22K shares), COMMERZBANK AKTIENGESELLSCHAFT /FI (17K shares), HSBC HOLDINGS PLC (15K shares), TOCQUEVILLE ASSET MANAGEMENT L.P. (15K shares), MORGAN STANLEY (13.4K shares), and UBS AG (4.67K shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.